Lv11
20 积分 2026-10-02 加入
[Chinese guidelines for the diagnosis and management of chronic obstructive pulmonary disease (2026 revision)]
18分钟前
待确认
Heart failure signal with mepolizumab in eosinophilic COPD
1个月前
已完结
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
1个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
1个月前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
1个月前
已完结